28 results
8-K
EX-10.1
INBS
Intelligent Bio Solutions Inc
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s … , in compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including, without limitation, the European Union
8-K
EX-1.1
INBS
Intelligent Bio Solutions Inc
4 Oct 23
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
5:27pm
to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s
424B4
INBS
Intelligent Bio Solutions Inc
3 Oct 23
Prospectus supplement with pricing info
4:52pm
to extensive regulation in the United States and abroad, including the European Union, our largest market for the IFP Drug Screening System. Government … Kingdom Accreditation Services (UKAS), FDA’s QSR and CE markings in the European Union. This covers procedures and documentation of the design
424B3
8gb8 zob4g
10 Jul 23
Prospectus supplement
5:11pm
8-K
EX-10.1
ab7 2q9y8
22 Dec 22
Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering
5:28pm
S-3
EX-4.7
fe0ymcoj0l3z
8 Apr 22
Shelf registration
5:27pm
S-3
EX-4.6
15vidrrnzcp eoe
8 Apr 22
Shelf registration
5:27pm